URSONORM

This brand name is authorized in Austria, Germany, Malta, Netherlands, UK.

Active ingredients

The drug URSONORM contains one active pharmaceutical ingredient (API):

1
UNII 724L30Y2QR - URSODIOL
 

The ursodeoxycholic acid converts lithogenic bile in non-lithogenic bile and gradually dissolves the cholesterol gallstones.
 
Read more about Ursodeoxycholic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A05AA02 Ursodeoxycholic acid A Alimentary tract and metabolism → A05 Bile and liver therapy → A05A Bile therapy → A05AA Bile acid preparations
Discover more medicines within A05AA02
A05B Liver therapy, lipotropics A Alimentary tract and metabolism → A05 Bile and liver therapy
Discover more medicines within A05B

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
DE Bundesinstitut für Arzneimittel und Medizinprodukte 15410838, 15410844, 15410850, 15410867
GB Medicines & Healthcare Products Regulatory Agency 369108, 369110, 369111
MT Medicines Authority AA565/57701
NL Z-Index G-Standaard, PRK 105759

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈